Clinical trial
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With…
NCT00469898 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00469898 |
|---|---|
| Title | Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | A Phase II Trial of Carboplatin and Irinotecan (CPT-11) as First-Line Therapy for Patients With Extensive Stage Small Cell Lung Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Carboplatin, irinotecan hydrochloride |
| Enrollment | 50 |
| Start date | Dec 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2010 |
| First posted | May 7, 2007 |
| Last update posted | Jul 27, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: